242x Filetype PDF File size 0.61 MB Source: www.hanmipharm.com
ASPEN 2021 Nutrition Science & Practice Conference
Intestinotrophic effect of a novel long-acting GLP-2 analog,
HM15912, in animal model for short bowel syndrome and
potential as monthly administration
Jae Hyuk Choi, JinBong Lee, EunJinPark, Sung Min Bae, DaeJinKim, Young HoonKim, In Young Choi
Sr. manager / Bio Discovery Team
HanmiPharm. Co., Ltd., Seoul, Republic of Korea
Disclosures
Employee of Hanmi Pharm. Co., Ltd.
ed.
All Rights Reserv
ition.
Nutr
Enteral
and
r Parenteral
fo
merican Society
A
|
ASPEN
© 2021
What GLP-2 is
Proglucagon 33 amino acids Various biological actions
Glicentin GLP-1 IP2 GLP-2 ↓ Food intake
GRPP OXM
ed. ↓ Bone resorption
All Rights Reserv ↓ Gastric motility &
ition. secretion
Nutr
Enteral
and Intestinal L cell ↑ Energy absorption &
mucosal morphology
r Parenteral - Intestinal growth
fo
- Mucosal integrity
merican Society
A
|
ASPEN
© 2021
What GLP-2 is
Proglucagon 33 amino acids Various biological actions
Glicentin GLP-1 IP2 GLP-2 ↓ Food intake
GRPP OXM
ed. ↓ Bone resorption
All Rights Reserv ↓ Gastric motility &
ition. “Crypt cell proliferation via GLP-2/IGF-1 axis” secretion
Nutr
Enteral
and Intestinal L cell ↑ Energy absorption &
mucosal morphology
r Parenteral - Intestinal growth
fo
- Mucosal integrity
merican Society
A
|
ASPEN
© 2021
no reviews yet
Please Login to review.